MedMen Crisis Deepens: Leadership Shakeup as Stock Crashes to Zero
LOS ANGELES – MedMen Enterprises Inc., once considered a cannabis unicorn, may be facing the legendary creature’s fate after a dramatic plunge in valuation and the sudden exit of more key executives. Chief Executive Officer Ellen Deutsch Harrison stepped down January 19 after less than seven months in the role. Hot on her heels, Executive Chairman Michael Serruya, whose private equity fund invested $100 million in MedMen in 2021, departed January 24. Their exits mark the latest in a series of rapid changes in the company’s executive suite since 2020. Once nicknamed “the Apple Store of weed” and credited with revolutionizing the dispensary experience, fourteen-year-old MedMen’s history is littered with executive turnover , financial missteps , and TMZ-worthy scandals . Co-founder Adam Bierman is among the former executives and investors who have sued the company, alleging fraud, financial mismanagement , and breach of contract, among other things. After Harrison’s and Serruya...